Used as a key chiral intermediate in the synthesis of antiviral medications and enzyme inhibitors. The tetrahydropyran ring structure mimics natural sugars and nucleotides, facilitating the development of selective glycosidase inhibitors and nucleoside analogs. This enables high target specificity, improved efficacy in drug formulations, and reduced side effects in medicinal chemistry applications.